Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.35 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10079107 | 0.98 | NPC1 (0.37) | NPC1RAB9ACNR2CYP3A4ACHE | |
| SCHEMBL12820203 | 0.90 | NPC1 (0.39) | NPC1RAB9ACNR2CYP3A4ACHE | |
| SCHEMBL10079131 | 0.90 | MEN1 (0.43) | CNR2CYP3A4ACHEHCRTR1ALDH1A1 | |
| SCHEMBL12253671 | 0.89 | NPC1 (0.41) | NPC1RAB9ACNR2CYP3A4ACHE | |
| SCHEMBL10079130 | 0.89 | MEN1 (0.42) | CNR2CYP3A4ACHEHCRTR1ALDH1A1 | |
| SCHEMBL10079123 | 0.89 | PTPN1 (0.34) | NPC1RAB9ACNR2CYP3A4ACHE | |
| SCHEMBL10079127 | 0.87 | CA12 (0.39) | CNR2CYP3A4ACHEHCRTR1ALDH1A1 | |
| SCHEMBL13815350 | 0.86 | MEN1 (0.42) | CNR2CYP3A4ACHEHCRTR1ALDH1A1 | |
| SCHEMBL797431 | 0.85 | CA12 (0.38) | CNR2CYP3A4ACHEHCRTR1ALDH1A1 | |
| SCHEMBL10079141 | 0.82 | NCEH1 (0.45) | NPC1RAB9AMEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8115197-B2 | Organic semiconductor material, organic semiconductor thin film and organic semiconductor device | SONY CORPORATION (JP) | 2012-02-14 | — | — | US | disclosed |
| US-8115197-B2 | Organic semiconductor material, organic semiconductor thin film and organic semiconductor device | SONY CORPORATION (JP) | 2012-02-14 | — | — | US | disclosed |
| US-20090230387-A1 | ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR THIN FILM AND ORGANIC SEMICONDUCTOR DEVICE | SONY CORPORATION (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20090140241-A1 | ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR THIN FILM AND ORGANIC SEMICONDUCTOR DEVICE | SONY CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090140241-A1 | ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR THIN FILM AND ORGANIC SEMICONDUCTOR DEVICE | H1-10, OR10J3, H1-0 | NPC1 3795/4885RAB9A 1825/4885CNR2 3388/4885 |
| US-20090230387-A1 | ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR THIN FILM AND ORGANIC SEMICONDUCTOR DEVICE | H1-10, OR10J3, H1-0 | NPC1 3795/4885RAB9A 1825/4885CNR2 3388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.